Cubist Pharmaceuticals, Inc. (CBST) Announces Management Change

Cubist Pharmaceuticals, Inc. (CBST) Announces Management Change

10/5/2012 10:16:22 AM

LEXINGTON, Mass.--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that Tamara Joseph, Senior Vice President and General Counsel, has resigned from the organization. The company has initiated a search for Ms. Joseph's successor.

Suggested Articles

Genentech followed a $1 billion pact with Sosei Heptares with discovery deals around cancer and neurological diseases with Skyhawk and Convelo.

The partners will use wearable devices to assess how heart failure patients function and feel after being discharged from hospitals.

After spinning out two companies at the start of the year, Sosei Heptares has now inked a new deal with Roche biologics unit Genentech.